PANICHELLA, GIORGIA
 Distribuzione geografica
Continente #
EU - Europa 386
NA - Nord America 197
AS - Asia 72
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 658
Nazione #
IT - Italia 193
US - Stati Uniti d'America 191
IE - Irlanda 143
GB - Regno Unito 19
CN - Cina 18
PK - Pakistan 13
HK - Hong Kong 12
FI - Finlandia 11
SG - Singapore 11
BD - Bangladesh 7
DE - Germania 5
IN - India 5
RO - Romania 5
CA - Canada 4
CH - Svizzera 3
NL - Olanda 3
SE - Svezia 3
BR - Brasile 2
SA - Arabia Saudita 2
AM - Armenia 1
AT - Austria 1
DO - Repubblica Dominicana 1
EU - Europa 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MX - Messico 1
Totale 658
Città #
Dublin 143
Chandler 60
Rome 19
Milan 17
Livorno 12
Florence 11
Helsinki 11
Hong Kong 11
San Mateo 10
Washington 10
Buti 8
Pisa 8
Beijing 7
Genoa 7
Palermo 7
Portsmouth 7
Boardman 6
Cambridge 6
Fremont 5
Lawrence 5
Lucca 5
Stevenage 5
Ashburn 4
Bucharest 4
Cascina 4
Gujranwala 4
Islamabad 4
Massa 4
Verona 4
Viareggio 4
Wilmington 4
Woodbridge 4
Amsterdam 3
Bari 3
Brescia 3
Cordenons 3
Dongguan 3
Fairfield 3
Hyderabad 3
Lahore 3
Ottawa 3
Parma 3
Acton 2
Al Qatif 2
Baronissi 2
Bengaluru 2
Casalecchio di Reno 2
Chicago 2
Corigliano Calabro 2
Cosenza 2
Follonica 2
Forlì 2
Hilden 2
L'aquila 2
Lausanne 2
London 2
Mariano Comense 2
Naples 2
Pavullo nel Frignano 2
Salemi 2
Salerno 2
San Giuliano Terme 2
Santa Croce sull'Arno 2
Trapani 2
West Jordan 2
Altopascio 1
Astana 1
Belo Horizonte 1
Bishkek 1
Bollebygd 1
Brooklyn 1
Cagliari 1
Cambiago 1
Chioggia 1
Chiswick 1
Contagem 1
Dera Ghazi Khan 1
Gaithersburg 1
Giovinazzo 1
Hanover 1
Hounslow 1
Mainz 1
Moio della Civitella 1
Montreal 1
New York 1
Nogara 1
Norwalk 1
Padova 1
Perugia 1
Prescot 1
Rawalpindi 1
Redmond 1
Santo Domingo Este 1
Tavagnacco 1
Tlalpan 1
Vidor 1
Wanchai 1
Yerevan 1
Zirl 1
Zurich 1
Totale 531
Nome #
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 119
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 75
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 75
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 59
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 56
Subclinical cardiac damage in cancer patients before chemotherapy 42
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 41
Role of Imaging in Cardiomyopathies 37
Pirfenidone as a novel cardiac protective treatment 29
Sex-related differences in ventricular remodeling after myocardial infarction 29
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity 25
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 23
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 11
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 7
RNA-targeting and gene editing therapies for transthyretin amyloidosis 7
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction 6
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 6
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 6
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis 5
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 5
Sex differences in transthyretin cardiac amyloidosis 4
The triglyceride/HDL cholesterol ratio and TyG index predict coronary atherosclerosis and outcome in the general population 4
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 4
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 3
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond 2
Totale 680
Categoria #
all - tutte 6.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202266 0 0 0 5 7 7 10 17 7 6 2 5
2022/2023367 5 28 10 21 44 40 14 47 109 10 27 12
2023/2024247 13 11 63 36 7 25 27 13 15 26 11 0
Totale 680